Effectiveness and safety of guselkumab in 50 patients with moderate to severe plaque psoriasis who had previously been treated with other biologics: a retrospective real-world evidence study

Publikation: Bidrag til tidsskriftLetterForskningfagfællebedømt

Standard

Effectiveness and safety of guselkumab in 50 patients with moderate to severe plaque psoriasis who had previously been treated with other biologics : a retrospective real-world evidence study. / Schwensen, J. F.B.; Nielsen, V. W.; Nissen, C. V.; Sand, C.; Gniadecki, R.; Thomsen, S. F.

I: Journal of the European Academy of Dermatology and Venereology, Bind 35, Nr. 5, 2021, s. e341-e343.

Publikation: Bidrag til tidsskriftLetterForskningfagfællebedømt

Harvard

Schwensen, JFB, Nielsen, VW, Nissen, CV, Sand, C, Gniadecki, R & Thomsen, SF 2021, 'Effectiveness and safety of guselkumab in 50 patients with moderate to severe plaque psoriasis who had previously been treated with other biologics: a retrospective real-world evidence study', Journal of the European Academy of Dermatology and Venereology, bind 35, nr. 5, s. e341-e343. https://doi.org/10.1111/jdv.17092

APA

Schwensen, J. F. B., Nielsen, V. W., Nissen, C. V., Sand, C., Gniadecki, R., & Thomsen, S. F. (2021). Effectiveness and safety of guselkumab in 50 patients with moderate to severe plaque psoriasis who had previously been treated with other biologics: a retrospective real-world evidence study. Journal of the European Academy of Dermatology and Venereology, 35(5), e341-e343. https://doi.org/10.1111/jdv.17092

Vancouver

Schwensen JFB, Nielsen VW, Nissen CV, Sand C, Gniadecki R, Thomsen SF. Effectiveness and safety of guselkumab in 50 patients with moderate to severe plaque psoriasis who had previously been treated with other biologics: a retrospective real-world evidence study. Journal of the European Academy of Dermatology and Venereology. 2021;35(5):e341-e343. https://doi.org/10.1111/jdv.17092

Author

Schwensen, J. F.B. ; Nielsen, V. W. ; Nissen, C. V. ; Sand, C. ; Gniadecki, R. ; Thomsen, S. F. / Effectiveness and safety of guselkumab in 50 patients with moderate to severe plaque psoriasis who had previously been treated with other biologics : a retrospective real-world evidence study. I: Journal of the European Academy of Dermatology and Venereology. 2021 ; Bind 35, Nr. 5. s. e341-e343.

Bibtex

@article{4f68592c9cbb4e3895c4cd0726fef030,
title = "Effectiveness and safety of guselkumab in 50 patients with moderate to severe plaque psoriasis who had previously been treated with other biologics: a retrospective real-world evidence study",
author = "Schwensen, {J. F.B.} and Nielsen, {V. W.} and Nissen, {C. V.} and C. Sand and R. Gniadecki and Thomsen, {S. F.}",
year = "2021",
doi = "10.1111/jdv.17092",
language = "English",
volume = "35",
pages = "e341--e343",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "Elsevier",
number = "5",

}

RIS

TY - JOUR

T1 - Effectiveness and safety of guselkumab in 50 patients with moderate to severe plaque psoriasis who had previously been treated with other biologics

T2 - a retrospective real-world evidence study

AU - Schwensen, J. F.B.

AU - Nielsen, V. W.

AU - Nissen, C. V.

AU - Sand, C.

AU - Gniadecki, R.

AU - Thomsen, S. F.

PY - 2021

Y1 - 2021

U2 - 10.1111/jdv.17092

DO - 10.1111/jdv.17092

M3 - Letter

C2 - 33338282

AN - SCOPUS:85099085956

VL - 35

SP - e341-e343

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

IS - 5

ER -

ID: 280555286